رجوع
35
46
نطاق اليوم
KWD 2.97
KWD 3.51
نطاق 52 أسبوعًا
KWD 2.97
KWD 3.51
حجم التداول
325
متوسط 50 يوم / 200 يوم
KWD 3.17
/
KWD 3.19
الإغلاق السابق
KWD 2.97
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 2.4 | 0.3 |
| P/B | 0.1 | 2.9 |
| ROE % | 4.2 | 3.7 |
| Net Margin % | 3.0 | 3.8 |
| Rev Growth 5Y % | 4.9 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 2.636
KWD 2.590 – KWD 2.676
|
12 B | 1 |
| FY2027 |
KWD 2.278
KWD 2.238 – KWD 2.313
|
11 B | 1 |
| FY2026 |
KWD 1.971
KWD 1.937 – KWD 2.002
|
11 B | 1 |
النقاط الرئيسية
Revenue grew 4.94% annually over 5 years — modest growth
Earnings declined -32.93% over the past year
ROE of 4.23% is below average
Debt/Equity of 0.17 — conservative balance sheet
Generating 755.10M in free cash flow
P/E of 2.42 — trading at a low valuation
النمو
Revenue Growth (5Y)
4.94%
Revenue (1Y)-2.59%
Earnings (1Y)-32.93%
FCF Growth (3Y)-28.01%
الجودة
Return on Equity
4.23%
ROIC7.14%
Net Margin3.04%
Op. Margin7.55%
الأمان
Debt / Equity
0.17
Current Ratio1.83
Interest Coverage3.99
التقييم
P/E Ratio
2.42
P/B Ratio0.11
EV/EBITDA1.49
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.59% | Revenue Growth (3Y) | 0.09% |
| Earnings Growth (1Y) | -32.93% | Earnings Growth (3Y) | -16.58% |
| Revenue Growth (5Y) | 4.94% | Earnings Growth (5Y) | -18.09% |
| Profitability | |||
| Revenue (TTM) | 11.00B | Net Income (TTM) | 334.00M |
| ROE | 4.23% | ROA | 2.23% |
| Gross Margin | 39.13% | Operating Margin | 7.55% |
| Net Margin | 3.04% | Free Cash Flow (TTM) | 755.10M |
| ROIC | 7.14% | FCF Growth (3Y) | -28.01% |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 1.83 |
| Interest Coverage | 3.99 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 2.42 | P/B Ratio | 0.11 |
| P/S Ratio | 0.07 | PEG Ratio | -0.76 |
| EV/EBITDA | 1.49 | Dividend Yield | 0.03% |
| Market Cap | 807.58M | Enterprise Value | 1.24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.00B | 11.29B | 10.98B | 9.98B | 9.07B |
| Net Income | 334.00M | 498.00M | 480.00M | 449.00M | 742.00M |
| EPS (Diluted) | 1.23 | 1.83 | 1.76 | 1.65 | 2.72 |
| Gross Profit | 4.30B | 4.91B | 4.74B | 4.21B | 4.21B |
| Operating Income | 831.00M | 893.00M | 884.00M | 691.00M | 1.08B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 14.98B | 16.28B | 15.44B | 16.17B | 14.61B |
| Total Liabilities | 7.52B | 7.94B | 7.86B | 8.54B | 7.73B |
| Shareholders' Equity | 7.46B | 8.34B | 7.58B | 7.62B | 6.89B |
| Total Debt | 1.27B | 5.42B | 5.49B | 6.31B | 5.45B |
| Cash & Equivalents | 836.00M | 892.00M | 923.00M | 949.00M | 757.00M |
| Current Assets | 4.32B | 4.85B | 4.42B | 5.03B | 4.17B |
| Current Liabilities | 2.37B | 4.60B | 4.40B | 4.62B | 6.49B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#551 of 827
#161 of 709
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026